Litcius/Paper detail

Ultrasensitive detection of multiple Alzheimer's disease biomarkers by SERS-LFA

Yuanbao Zhan, Ruihua Fei, Lu Yu, Yu Wan, Xuming Wu, Jian Dong, Dianhuai Meng, Qinyu Ge, Xiangwei Zhao

2022The Analyst40 citationsDOI

Abstract

, respectively, which are two orders of magnitude lower than their concentrations in blood. Compared with the existing detection technology, SERS-LFA has the advantages of high specificity, high sensitivity, low cost, multiple detection, and rapid detection. Therefore, SERS-LFA has a broad application prospect in the early diagnosis and monitoring of AD in the future.

Topics & Concepts

Point-of-care testingDetection limitAlzheimer's diseaseMedicineDiseaseNanotechnologyChemistryPathologyMaterials scienceChromatographyGold and Silver Nanoparticles Synthesis and ApplicationsCarbon and Quantum Dots ApplicationsNanocluster Synthesis and Applications
Ultrasensitive detection of multiple Alzheimer's disease biomarkers by SERS-LFA | Litcius